Literature DB >> 3521798

The comparative efficacy of cimetidine and ranitidine in controlling gastric pH in critically ill patients.

S R Reid, C D Bayliff.   

Abstract

The comparative efficacy of intravenous cimetidine and ranitidine in controlling gastric pH in 100 intensive care unit patients was assessed in a double blind, prospective, randomized study. The total number of gastric pH determinations and the number of pH determinations with pH less than five were recorded. Patients received either cimetidine or ranitidine via continuous infusion, with dosage adjustments for patients with renal insufficiency. Antacids were administered each time the gastric pH was less than five. There was no difference overall in the number of patients who had at least one gastric pH determination less than pH 5. There was however, a larger proportion of patients with greater than or equal to 10, greater than or equal to 15, greater than or equal to 20 and greater than or equal to 25 per cent of gastric pH determination less than pH 5 in the cimetidine group than in the ranitidine group. This difference was statistically significant for greater than or equal to 25 per cent. The drugs were well tolerated. Ranitidine was as effective as cimetidine and possibly more so in controlling gastric pH.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3521798     DOI: 10.1007/bf03010739

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  22 in total

1.  Perforation of chronic peptic ulcers after cimetidine.

Authors: 
Journal:  Br Med J       Date:  1977-10-29

2.  Ranitidine suppression of gastric hypersecretion resistant to cimetidine.

Authors:  M Danilewitz; L O Tim; B Hirschowitz
Journal:  N Engl J Med       Date:  1982-01-07       Impact factor: 91.245

3.  Failure of gastric pH control by antacids or cimetidine in the critically ill: a valid sign of sepsis.

Authors:  L F Martin; M H Max; H C Polk
Journal:  Surgery       Date:  1980-07       Impact factor: 3.982

4.  Gastric secretory and mucosal injury response to severe head trauma.

Authors:  S K Gudeman; C B Wheeler; J D Miller; L G Halloran; D P Becker
Journal:  Neurosurgery       Date:  1983-02       Impact factor: 4.654

5.  Duodenal perforation after cimetidine.

Authors:  P Hoste; J Ingels; A Elewaut; F Barbier
Journal:  Lancet       Date:  1978-03-25       Impact factor: 79.321

6.  Randomized prospective evaluation of cimetidine and antacid control of gastric pH in the critically ill.

Authors:  J C Stothert; D A Simonowitz; E P Dellinger; M Farley; W A Edwards; A D Blair; R Cutler; C J Carrico
Journal:  Ann Surg       Date:  1980-08       Impact factor: 12.969

7.  Cimetidine affords protection equal to antacids in prevention of stress ulceration following thermal injury.

Authors:  H P McElwee; K R Sirinek; B A Levine
Journal:  Surgery       Date:  1979-10       Impact factor: 3.982

Review 8.  Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

9.  Dose and serum concentration relationships in cimetidine-associated mental confusion.

Authors:  B J Kimelblatt; F B Cerra; G Calleri; M J Berg; M A McMillen; J J Schentag
Journal:  Gastroenterology       Date:  1980-04       Impact factor: 22.682

Review 10.  Cimetidine. I. Developments, pharmacology, and efficacy.

Authors:  J W Freston
Journal:  Ann Intern Med       Date:  1982-10       Impact factor: 25.391

View more
  7 in total

1.  pH-feedback controlled infusions of ranitidine are no more effective than fixed-dose infusions in reducing gastric acidity and variability in antisecretory responses.

Authors:  C H Wilder-Smith; F Halter; W Häcki; H S Merki
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

2.  Comparison of omeprazole and ranitidine for stress ulcer prophylaxis.

Authors:  M J Levy; C B Seelig; N J Robinson; J E Ranney
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

3.  Living wills: a solution to the prolonged act of dying?

Authors:  C S Houston
Journal:  CMAJ       Date:  1988-08-01       Impact factor: 8.262

Review 4.  Safety of acid-suppressing drugs.

Authors:  R A Smallwood; R G Berlin; N Castagnoli; H P Festen; C J Hawkey; S K Lam; M J Langman; P Lundborg; A Parkinson
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

Review 5.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

6.  Career and practice profiles of Alberta medical graduates (1973-85) practising in Alberta.

Authors:  P Jennett; K L Hunter
Journal:  CMAJ       Date:  1988-10-01       Impact factor: 8.262

Review 7.  Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units.

Authors:  Ingrid Toews; Aneesh Thomas George; John V Peter; Richard Kirubakaran; Luís Eduardo S Fontes; Jabez Paul Barnabas Ezekiel; Joerg J Meerpohl
Journal:  Cochrane Database Syst Rev       Date:  2018-06-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.